| SCHEDULE OF SHARE OPTION ACTIVITY |
The
following table sets forth the share option activities for the fiscal year ended March 31, 2024, the nine months ended December 31, 2024
and the year ended December 31, 2025:
SCHEDULE OF SHARE OPTION ACTIVITY
| | |
Number
of shares | | |
Weighted-average
exercise price | | |
Weighted
average remaining contractual term | | |
Aggregate
intrinsic value | | |
Weighted
average fair value of options | |
| | |
| | |
US$ | | |
YEARS | | |
US$’000 | | |
US$ | |
| | |
| | |
| | |
| | |
| | |
| |
| Outstanding as of March 31,
2023 | |
| 26,656,618 | | |
| 0.48 | | |
| 6.83 | | |
| 9,585.96 | | |
| 0.88 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | |
| Granted | |
| 22,064,611 | | |
| -* | | |
| - | | |
| - | | |
| 0.04 | |
| Forfeited | |
| (4,522,500 | ) | |
| 0.86 | | |
| - | | |
| - | | |
| 1.81 | |
| Exercised | |
| (6,880,590 | ) | |
| -* | | |
| - | | |
| - | | |
| 0.11 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | |
| Outstanding as of March 31, 2024 | |
| 37,318,139 | | |
| 0.24 | | |
| 7.67 | | |
| 8,898.37 | | |
| 0.44 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | |
| Granted | |
| 10,544,400 | | |
| -* | | |
| - | | |
| - | | |
| 0.01 | |
| Forfeited | |
| (2,078,339 | ) | |
| 0.90 | | |
| - | | |
| - | | |
| 1.68 | |
| Exercised | |
| (14,181,600 | ) | |
| -* | | |
| - | | |
| - | | |
| 0.04 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | |
| Outstanding as of December 31, 2024 | |
| 31,602,600 | | |
| 0.21 | | |
| 3.60 | | |
| 14,336.67 | | |
| 0.38 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | |
| Granted | |
| 215,822,400 | | |
| -* | | |
| - | | |
| - | | |
| 0.01 | |
| Forfeited | |
| (6,758,400 | ) | |
| 0.07 | | |
| - | | |
| - | | |
| 0.15 | |
| Exercised | |
| (170,400 | ) | |
| -* | | |
| - | | |
| - | | |
| 0.14 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | |
| Outstanding as of December 31, 2025 | |
| 240,496,200 | | |
| 0.02 | | |
| 2.61 | | |
| 2,604.33 | | |
| 0.05 | |
| Vested and expected to vest as of December
31, 2025 | |
| 240,496,200 | | |
| 0.02 | | |
| 2.61 | | |
| 2,604.33 | | |
| 0.05 | |
| Exercisable as of December 31, 2025 | |
| 31,853,700 | | |
| 0.12 | | |
| 2.43 | | |
| 262.67 | | |
| 0.36 | |
|
| SCHEDULE OF RESTRICTED SHARE ACTIVITY |
The
following table sets forth the restricted share activity for the fiscal year ended March 31, 2024, the nine months ended December 31,
2024 and the year ended December 31, 2025:
SCHEDULE OF RESTRICTED SHARE ACTIVITY
| | |
Number
of
shares | | |
Weighted
average
grant
date
fair
value | |
| | |
| | |
US$ | |
| | |
| | |
| |
| Unvested as of March 31, 2023 | |
- | | |
- | |
| | |
| | |
| |
| Granted | |
| 2,871,270 | | |
| 0.05 | |
| Vested | |
| (2,871,270 | ) | |
| 0.05 | |
| | |
| | | |
| | |
| Unvested as of March 31, 2024 | |
| - | | |
| - | |
| | |
| | | |
| | |
| Granted | |
| - | | |
| - | |
| Vested | |
| - | | |
| - | |
| | |
| | | |
| | |
| Unvested as of December 31, 2024 | |
| - | | |
| - | |
| | |
| | | |
| | |
| Granted | |
| 55,200,600 | | |
| 0.01 | |
| Vested | |
| (55,200,600 | ) | |
| 0.01 | |
| | |
| | | |
| | |
| Unvested as of December 31, 2025 | |
| - | | |
| - | |
|
| SCHEDULE OF SHARE-BASED COMPENSATION EXPENSES BY FUNCTION |
The
following table sets forth the amounts of share-based compensation expense included in each of the relevant financial statement line
items:
SCHEDULE OF SHARE-BASED COMPENSATION EXPENSES BY FUNCTION
| | |
For
the fiscal
year
ended
March
31, | | |
For
the nine
months
ended
December
31, | | |
For
the year
ended
December
31, | |
| | |
2024 | | |
2024 | | |
2025 | |
| | |
RMB | | |
RMB | | |
RMB | |
| | |
| | | |
| | | |
| | |
| General and administrative expenses | |
| 72,942 | | |
| 84,663 | | |
| 36,780 | |
| Research and development expenses | |
| 1,420 | | |
| 128 | | |
| 2,491 | |
| Sales and marketing expenses | |
| 1,444 | | |
| 136 | | |
| 5,312 | |
| Total | |
| 75,806 | | |
| 84,927 | | |
| 44,583 | |
|